Elevated serum CA19-9 levels in poorly controlled diabetic patients.

Area of Science:

• Endocrinology
• Clinical Chemistry

Background:

• Serum CA19-9 is typically associated with gastrointestinal cancers.
• Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels.

Purpose of the Study:

• To investigate the relationship between serum CA19-9 levels and glycemic control in diabetic patients.
• To explore the correlation of CA19-9 with diabetic complications.

Main Methods:

• Serum CA19-9 levels were measured in 60 diabetic patients and 40 healthy controls.
• Correlations were assessed with hemoglobin A1 (HbA1), fasting plasma glucose, lipids, and diabetes duration.
• CA19-9 levels were compared between patients with and without diabetic complications.

Main Results:

• Serum CA19-9 levels were significantly correlated with HbA1 (r=0.4368) and fasting plasma glucose (r=0.3410).
• Poorly controlled diabetic patients (HbA1 >13% or glucose >200 mg/dl) showed a 50% positive rate for elevated CA19-9, compared to 10% in well-controlled patients.
• Elevated CA19-9 was observed in patients with diabetic retinopathy or proteinuria.

Conclusions:

• Serum CA19-9 levels are increased in diabetic patients, particularly those with poor glycemic control and complications.
• Fasting plasma glucose and HbA1 levels should be considered in patients presenting with elevated CA19-9.
• While not a malignancy, elevated CA19-9 in diabetes may serve as a marker for metabolic derangement and associated complications.